Sentence examples for extended disease from inspiring English sources

This extended DISEASE metaphor talks about corruption without mentioning it directly.

Because of the fact that it was the first PRRT study in Poland, patients had extended disease.

On the other hand, no difference in monocyte responsiveness was found when HNSCC patients with limited versus extended disease were compared.

When limited versus extended disease patients were compared, the patients were dichotomised by the median of the numeric sum of T and N stage, i.e. the T and N integer score (TANIS) [ 21] Scores between 0 and 3 were considered as limited disease and scores between 4 and 7 as extended disease.

From the time of diagnosis, the median survival rates for SCLCs are 15 20 (limited disease SCLC) and 8 13 months (extended disease SCLC), respectively (Puglisi et al, 2010); therefore, new therapeutic strategies are urgently needed.

This features allow a very comprehensive assessment of diabetic patients: patients with limited disease have a quite good prognosis of an ∼0.5% annual event rate and could continue to receive conventional medical therapy and patients with more extended disease could benefit from a vigorous treatment of both diabetes and CAD.

The addition of anthracyclines to combination chemotherapy regimens has extended disease-free and overall survival rates in both premenopausal and post-menopausal women, including those with ER-positive tumours.

Despite this gradual adaptation, double-transgenic mice showed extended disease-free survival and histological assessment of spleens of phenotypically healthy mice killed after 8 or 12 months showed clearly improved splenic architecture, reduced follicle and germinal center size and no lymphatic infiltrates in the liver parenchyma, in clear contrast to findings made in age-matched Vav-Bcl2 mice.

Double autologous transplantation clearly provides an overall survival advantage, with an extended disease-free survival, while reduced-dose-intensity allogeneic transplantation has opened the door to many more patients for this treatment option (Kroger et al, 2002; Attal et al, 2003; Harousseau et al, 2005).

Hence, it is essential to incorporate these valuable Pi- and Xa- genes into commercial elite lines, which will extend disease resistance longevity in released varieties.

Thus, novel and effective anti-cancer therapies are needed to encounter this extending disease.